Nemaura Medical Inc. Profile
Industry
Medical - DevicesSector
HealthcareNumber of Employees
36Nemaura Medical's Business Model
Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.
About Nemaura Medical
Website: https://nemauramedical.com
CEO (Chief Executive Officer): Dr. Dewan Fazlul Hoque Chowdhury Ph.D.
IPO date: 2018-02-05
Contact
Country: US
Address: 57 West 57th Street
City: New York
State: NY
Phone: 646 416 7912
Zip Code: 10019
Other
CIK: 0001602078
ISIN: US6404422080
CUSIP: 640442208
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
